COMMUNIQUÉS West-GlobeNewswire

Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
23/07/2026
Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications THE WOODLANDS, TX, [...]
Revolver Brewing Becomes Revolver Beer and Spirits, Extending the Blood & Honey Brand into Whiskey, Gin and Vodka
23/07/2026
New spirits line brings the bold blood orange and honey profile of Revolver’s iconic Blood & Honey beer to Whiskey, Gin and Vodka launching exclusively in Texas BRECKENRIDGE, Colo., July 23, 2026 (GLOBE NEWSWIRE [...]
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
23/07/2026
LAS VEGAS, July 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a developer of science-driven wellness products, today announces the successful completion of its commercial manufacturing and [...]
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026
First global approval of a once-daily, orally administered, Complement Factor B inhibitor Approval based on robust efficacy and safety data from Haisco's broad completed clinical development program in PNH Ciprocopan [...]
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
23/07/2026
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing. Healthcare Holding Schweiz is managed by Winterberg [...]
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and [...]
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
23/07/2026
Sòphia High Tech designs and manufactures ROMAN units for the remote inspection and maintenance of the RFX-mod2 fusion experiment, combining its precision manufacturing capabilities with the robotics expertise of [...]
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
23/07/2026
Strong second quarter performance with $1.5 billion in global product net sales, representing 60% year-over-year growth and 17% quarter-over-quarter growth Successfully launched VYVGART and VYVGART Hytrulo in anti-AChR [...]
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and [...]
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
23/07/2026
Group sales were +6% at constant exchange rates (CER) 1 , -2% when reported in CHF and +8% in USD 2 , in the first six months, driven by high demand for innovative medicines and diagnostics. Pharmaceuticals Division [...]
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
23/07/2026
MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January [...]
Hundreds of leaders, experts and organisations urge future UN Secretary-General to commit, act and deliver on gender equality as the United Nations faces historic test
23/07/2026
LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- As of today, over 200 current and former heads of state, UN leaders, organisations, advocates, practitioners, and researchers from all regions of the world are calling on the [...]
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026
22/07/2026
ROCKVILLE, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
The Lundquist Institute Launches the Nation's First Adult Exercise Medicine Fellowship
22/07/2026
New physician fellowship, leadership of the Academy of Exercise Medicine, and groundbreaking scientific research position The Lundquist Institute at the forefront of the emerging field of Exercise Medicine. Los Angeles [...]
Serina Therapeutics Appoints Farrell Simon to its Board of Directors
22/07/2026
HUNTSVILLE, Ala., July 22, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company advancing its proprietary POZ Platform ™ drug [...]
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
22/07/2026
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market [...]
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
FREMONT, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced that it will report financial results for the second quarter of 2026 after [...]
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
MENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
22/07/2026
WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, [...]

Pages